Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Transmission dynamics study of tuberculosis isolates with whole genome sequencing in southern Sweden.

Alaridah N, Hallbäck ET, Tångrot J, Winqvist N, Sturegård E, Florén-Johansson K, Jönsson B, Tenland E, Welinder-Olsson C, Medstrand P, Kaijser B, Godaly G.

Sci Rep. 2019 Mar 20;9(1):4931. doi: 10.1038/s41598-019-39971-z.

2.

A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis.

Tenland E, Krishnan N, Rönnholm A, Kalsum S, Puthia M, Mörgelin M, Davoudi M, Otrocka M, Alaridah N, Glegola-Madejska I, Sturegård E, Schmidtchen A, Lerm M, Robertson BD, Godaly G.

Tuberculosis (Edinb). 2018 Dec;113:231-238. doi: 10.1016/j.tube.2018.10.008. Epub 2018 Oct 30.

3.

Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".

Köser CU, Heyckendorf J, Andres S, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00616-18. doi: 10.1128/AAC.00616-18. Print 2018 Aug. No abstract available.

4.

Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.

König Walles J, Tesfaye F, Jansson M, Tolera Balcha T, Winqvist N, Kefeni M, Garoma Abeya S, Belachew F, Sturegård E, Björkman P.

PLoS One. 2018 Apr 4;13(4):e0193589. doi: 10.1371/journal.pone.0193589. eCollection 2018.

5.

Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.

Reepalu A, Balcha TT, Sturegård E, Medstrand P, Björkman P.

Open Forum Infect Dis. 2017 Oct 8;4(4):ofx219. doi: 10.1093/ofid/ofx219. eCollection 2017 Fall.

6.

What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.

Heyckendorf J, Andres S, Köser CU, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01550-17. doi: 10.1128/AAC.01550-17. Print 2018 Feb.

7.

A borderline range for Quantiferon Gold In-Tube results.

Jonsson J, Westman A, Bruchfeld J, Sturegård E, Gaines H, Schön T.

PLoS One. 2017 Nov 2;12(11):e0187313. doi: 10.1371/journal.pone.0187313. eCollection 2017.

8.

Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.

Reepalu A, Balcha TT, Skogmar S, Güner N, Sturegård E, Björkman P.

PLoS One. 2016 Jun 7;11(6):e0156602. doi: 10.1371/journal.pone.0156602. eCollection 2016.

9.

ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNγ-mediated autophagy and growth restriction of intracellular mycobacteria.

Lienard J, Movert E, Valfridsson C, Sturegård E, Carlsson F.

Cell Microbiol. 2016 Oct;18(10):1471-85. doi: 10.1111/cmi.12594. Epub 2016 Apr 13.

PMID:
27062290
10.

Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.

Skogmar S, Schön T, Balcha TT, Sturegård E, Jansson M, Björkman P.

PLoS One. 2015 Dec 2;10(12):e0144292. doi: 10.1371/journal.pone.0144292. eCollection 2015.

11.

Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.

Reepalu A, Balcha TT, Yitbarek T, Jarso G, Sturegård E, Björkman P.

BMC Res Notes. 2015 Nov 23;8:702. doi: 10.1186/s13104-015-1707-6.

12.

Impaired CXCR1-dependent oxidative defence in active tuberculosis patients.

Alaridah N, Winqvist N, Håkansson G, Tenland E, Rönnholm A, Sturegård E, Björkman P, Godaly G.

Tuberculosis (Edinb). 2015 Dec;95(6):744-750. doi: 10.1016/j.tube.2015.07.008. Epub 2015 Aug 14.

13.

Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding.

Balcha TT, Skogmar S, Sturegård E, Björkman P, Winqvist N.

Glob Health Action. 2015 Mar 27;8:27048. doi: 10.3402/gha.v8.27048. eCollection 2015.

14.

A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers.

Balcha TT, Skogmar S, Sturegård E, Schön T, Winqvist N, Reepalu A, Jemal ZH, Tibesso G, Björk J, Björkman P.

Open Forum Infect Dis. 2014 Oct 10;1(3):ofu095. doi: 10.1093/ofid/ofu095. eCollection 2014 Dec.

15.

High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in ethiopian health centers irrespective of concomitant tuberculosis.

Reepalu A, Balcha TT, Skogmar S, Jemal ZH, Sturegård E, Medstrand P, Björkman P.

Open Forum Infect Dis. 2014 Jun 19;1(1):ofu039. doi: 10.1093/ofid/ofu039. eCollection 2014 Mar.

16.

Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.

Sturegård E, Ängeby KA, Werngren J, Juréen P, Kronvall G, Giske CG, Kahlmeter G, Schön T.

Clin Microbiol Infect. 2015 Feb;21(2):148.e5-7. doi: 10.1016/j.cmi.2014.08.021. Epub 2014 Oct 29.

17.

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis.

Reepalu A, Balcha TT, Skogmar S, Jemal ZH, Sturegård E, Medstrand P, Björkman P.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19612. doi: 10.7448/IAS.17.4.19612. eCollection 2014.

18.

Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L, Schön T, Simonsson US, Bruchfeld J, Larsson M, Juréen P, Sturegård E, Giske CG, Ängeby K.

Antimicrob Agents Chemother. 2014 Dec;58(12):7557-9. doi: 10.1128/AAC.02995-14. Epub 2014 Sep 22.

19.

Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres.

Balcha TT, Winqvist N, Sturegård E, Skogmar S, Reepalu A, Jemal ZH, Tibesso G, Schön T, Björkman P.

Trop Med Int Health. 2014 Jun;19(6):734-742. doi: 10.1111/tmi.12308. Epub 2014 Mar 29.

20.

Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.

Balcha TT, Sturegård E, Winqvist N, Skogmar S, Reepalu A, Jemal ZH, Tibesso G, Schön T, Björkman P.

PLoS One. 2014 Jan 22;9(1):e85478. doi: 10.1371/journal.pone.0085478. eCollection 2014.

21.

Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.

Hoffner S, Angeby K, Sturegård E, Jönsson B, Johansson A, Sellin M, Werngren J.

Int J Tuberc Lung Dis. 2013 Nov;17(11):1486-90. doi: 10.5588/ijtld.13.0195.

PMID:
24125455
22.

Risk of inflammatory bowel disease following Bacille Calmette-Guérin and smallpox vaccination: a population-based Danish case-cohort study.

Villumsen M, Jess T, Sørup S, Ravn H, Sturegård E, Benn CS, Aaby P, Roth A.

Inflamm Bowel Dis. 2013 Jul;19(8):1717-24. doi: 10.1097/MIB.0b013e318281f34e.

PMID:
23624886
23.

Human papillomavirus typing in reporting of condyloma.

Sturegård E, Johansson H, Ekström J, Hansson BG, Johnsson A, Gustafsson E, Dillner J, Forslund O.

Sex Transm Dis. 2013 Feb;40(2):123-9. doi: 10.1097/OLQ.0b013e31827aa9b3. Erratum in: Sex Transm Dis. 2013 Sep;40(9):760.

PMID:
23324975
24.

A case of Mycobacterium goodii prosthetic valve endocarditis in a non-immunocompromised patient: use of 16S rDNA analysis for rapid diagnosis.

Jönsson G, Rydberg J, Sturegård E, Christensson B.

BMC Infect Dis. 2012 Nov 14;12:301. doi: 10.1186/1471-2334-12-301.

25.

[Fatal disseminated nocardiosis. However the prognosis is good in early diagnosis and treatment].

Janols H, Ahl J, Sturegård E.

Lakartidningen. 2011 Dec 21;108(51-52):2722-4. Swedish. No abstract available.

PMID:
22375501
26.

Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.

Werngren J, Sturegård E, Juréen P, Ängeby K, Hoffner S, Schön T.

Antimicrob Agents Chemother. 2012 Mar;56(3):1253-7. doi: 10.1128/AAC.05894-11. Epub 2011 Dec 27.

27.

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.

Schön T, Juréen P, Chryssanthou E, Giske CG, Sturegård E, Kahlmeter G, Hoffner S, Angeby KA.

Int J Tuberc Lung Dis. 2011 Apr;15(4):502-9. doi: 10.5588/ijtld.10.0238.

PMID:
21396210
28.

Reducing blood culture contamination by a simple informational intervention.

Roth A, Wiklund AE, Pålsson AS, Melander EZ, Wullt M, Cronqvist J, Walder M, Sturegård E.

J Clin Microbiol. 2010 Dec;48(12):4552-8. doi: 10.1128/JCM.00877-10. Epub 2010 Sep 29.

29.

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.

Angeby KA, Jureen P, Giske CG, Chryssanthou E, Sturegård E, Nordvall M, Johansson AG, Werngren J, Kahlmeter G, Hoffner SE, Schön T.

J Antimicrob Chemother. 2010 May;65(5):946-52. doi: 10.1093/jac/dkq091. Epub 2010 Mar 23.

PMID:
20332195
30.

Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.

Juréen P, Angeby K, Sturegård E, Chryssanthou E, Giske CG, Werngren J, Nordvall M, Johansson A, Kahlmeter G, Hoffner S, Schön T.

J Clin Microbiol. 2010 May;48(5):1853-8. doi: 10.1128/JCM.00240-10. Epub 2010 Mar 17.

31.

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.

Schön T, Juréen P, Giske CG, Chryssanthou E, Sturegård E, Werngren J, Kahlmeter G, Hoffner SE, Angeby KA.

J Antimicrob Chemother. 2009 Oct;64(4):786-93. doi: 10.1093/jac/dkp262. Epub 2009 Jul 23.

PMID:
19633001
32.

[Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project].

Sturegård E, Johnsson A, Gustafsson E, Dillner J.

Lakartidningen. 2008 Dec 10-16;105(50):3648-50. Swedish. No abstract available.

PMID:
19177930
33.

Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice.

Stenström B, Zhao CM, Rogers AB, Nilsson HO, Sturegård E, Lundgren S, Fox JG, Wang TC, Wadström TM, Chen D.

Carcinogenesis. 2007 Sep;28(9):2041-6. Epub 2007 Mar 26.

PMID:
17389611
34.

Gastric bypass surgery does not increase susceptibility to Helicobacter pylori infection in the stomach of rat or mouse.

Stenström B, Løseth K, Bevanger L, Sturegård E, Wadström T, Chen D.

Inflammopharmacology. 2005;13(1-3):229-34.

PMID:
16259742
35.

Lectin histochemistry of the gastric mucosa in normal and Helicobacter pylori infected guinea-pigs.

Lueth M, Sturegård E, Sjunnesson H, Wadström T, Schumacher U.

J Mol Histol. 2005 Feb;36(1-2):51-8.

PMID:
15703999
36.

Helicobacter species in human colon biopsies.

Sturegård E, Hertervig E, Sjunnesson H, Wadström T.

Aliment Pharmacol Ther. 2004 Mar 1;19(5):613-4. No abstract available.

37.

PCR-denaturing gradient gel electrophoresis and two feces antigen tests for detection of Helicobacter pylori in mice.

Sjunnesson H, Fält T, Sturegård E, Abu Al-Soud W, Ljungh A, Wadström T.

Curr Microbiol. 2003 Oct;47(4):278-85.

PMID:
14629007
38.

Five month persistence of Helicobacter pylori infection in guinea pigs.

Sjunnesson H, Sturegard E, Hynes S, Willen R, Feinstein R, Wadstrom T.

APMIS. 2003 Jun;111(6):634-42.

PMID:
12969019
39.

High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig.

Sjunnesson H, Sturegård E, Willén R, Wadström T.

Comp Med. 2001 Oct;51(5):418-23.

PMID:
11924801
40.

Comparative study of Helicobacter pylori infection in guinea pigs and mice - elevation of acute-phase protein C3 in infected guinea pigs.

Sjunnesson H, Sturegård E, Grubb A, Willén R, Wadström T.

FEMS Immunol Med Microbiol. 2001 Mar;30(2):167-72.

41.

Infection with cagA- and vacA-positive and -negative strains of Helicobacter pylori in a mouse model.

Sturegård E, Sjunnesson H, Nilsson H, Andersson R, Areskoug C, Wadström T.

FEMS Immunol Med Microbiol. 2001 Mar;30(2):115-20.

42.

The relationship between O-chain expression and colonisation ability of Helicobacter pylori in a mouse model.

Moran AP, Sturegård E, Sjunnesson H, Wadström T, Hynes SO.

FEMS Immunol Med Microbiol. 2000 Dec;29(4):263-70.

43.

Severe gastritis in guinea-pigs infected with Helicobacter pylori.

Sturegård E, Sjunnesson H, Ho B, Willén R, Aleljung P, Ng HC, Wadström T.

J Med Microbiol. 1998 Dec;47(12):1123-9.

PMID:
9856649
44.

Dietary factors influence the recovery rates of Helicobacter pylori in a BALB/cA mouse model.

Wang X, Sjunnesson H, Sturegård E, Wadström T, Willén R, Aleljung P.

Zentralbl Bakteriol. 1998 Oct;288(2):195-205.

PMID:
9809401
45.

Infection of BALB/c A mice by spiral and coccoid forms of Helicobacter pylori.

Wang X, Sturegård E, Rupar R, Nilsson HO, Aleljung PA, Carlén B, Willén R, Wadström T.

J Med Microbiol. 1997 Aug;46(8):657-63.

PMID:
9511813

Supplemental Content

Loading ...
Support Center